• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·603067.SS
Share

Hubei Zhenhua Chemical Co.,Ltd. Stocks

CN¥ 45Last Updated 22.05.2026

Issuer Rating

3/7
Performance

Modest

Risk

Moderate

Recommendation

Sell

Market Cap

CN¥ 4.64B

CN¥ 45
Key Takeaways

Risk factor

High price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Hubei Zhenhua Chemical Co.,Ltd. engages in the research, development, production, and marketing of chromium salt products in China. The company offers sodium bichromate and dichromate, chromic acid anhydride, crystal chromic acid anhydride, liquid chromic anhydride, chrome oxide green, chromic trioxide, potassium dichromate, basic chrome sulphate, vitamin K3, sodium sulphate anhydrous, aluminium hydroxide, etc. It also exports its products to Europe, the United States, Africa, and Southeast Asia. The company was formerly known as Huanghsi Zhenhua Chemical Industry Co., Ltd. Hubei Zhenhua Chemical Co.,Ltd. was founded in 1967 and is based in Huangshi, China.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' o

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.05.2026 02:09

Deal with Iran that would open the Strait of Hormuz is almost agreed upon - Trump

23.05.2026 16:01

Highlights in small-caps: Ebola vaccine, SpaceX IPO beneficiaries, newcomers to Russell

23.05.2026 13:01

Highlights of the week: SpaceX development plans, Nvidia reporting, new Nebius competitor

23.05.2026 03:19

Anthropic is preparing a new round of investment with a valuation higher than OpenAI - Bloomberg

23.05.2026 03:04

Billionaires including Musk and Zuckerberg convinced Trump to delay AI executive order - WP

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026